ESMO Annual Meeting 2024

SAKK at ESMO 2024

Highlighting Key Research with proffered paper, one oral presentation and three poster presentations

SAKK at ESMO 2024

Highlighting Key Research with proffered paper, one oral presentation and three poster presentations

From September 13 to 17, the Swiss Group for Clinical Cancer Research (SAKK) will have a significant presence at ESMO 2024. Prof. Dr. med. Ulrich Güller will have a proffered paper presentation about the SAKK 41/13 trial and Prof. Dr. Silke Gillessen will present STAMPEDE in a mini-oral presentation. Additionally, three SAKK trials will be showcased through poster presentations:

  • SAKK 15/19 by Prof. Dr. med. Alfredo Addeo
  • SAKK 16/96, 16/00, 16/01, 16/08, and 16/14 by Dr. med. Lorenz Frehner
  • SAKK 21/18 (meta-analysis) by Dr. med. Louis Boismoreau

Don’t miss this opportunity to engage with cutting-edge oncology research. Attend these sessions to see the results and engage in discussions.

Download Press Release (German)

SAKK Presentations at ESMO 2024

Download Press Release (German)

Abstract_Aspirin_SAKK_41_13

Download Press Release (German)

Medienmitteilung SAKK41/13 Spital STS AG

All News